These Analysts Revise Their Forecasts On Evolent Health After Upbeat Results
Portfolio Pulse from Avi Kapoor
Evolent Health, Inc. (NYSE:EVH) reported Q4 earnings of 23 cents per share, surpassing estimates of 15 cents. Sales were $556.05 million, exceeding expectations of $542.39 million. CEO Seth Blackley highlighted a strong year with over 45% annual revenue growth and successful integration of NIA. Shares rose 11.5% to $33.20. Canaccord Genuity and JMP Securities adjusted their price targets on EVH following the results.
February 23, 2024 | 7:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Evolent Health reported Q4 earnings and sales above estimates, leading to an 11.5% increase in share price to $33.20. Analysts from Canaccord Genuity and JMP Securities revised their price targets.
The positive earnings report and sales figures exceeding expectations have led to a significant increase in share price. Analysts' adjustments to price targets reflect confidence in EVH's future performance, likely contributing to continued investor interest.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100